About Translumina
Translumina is a company based in Hechingen (Germany) founded in 2010. The company has 363 employees as of February 08, 2025. Translumina has completed 2 acquisitions, including Blue Medical and Lamed. Translumina offers products and services including Drug Eluting Stents, Drug Eluting Balloons, PTCA Balloons, and Coronary Balloons. Translumina operates in a competitive market with competitors including SMT, InspireMD, Vesper Medical, Endospan and Biosensors International, among others.
- Headquarter Hechingen, Germany
- Employees 363 as on 08 Feb, 2025
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Translumina Therapeutics Llp
- Date of Incorporation 01 Dec, 2009
- Jurisdiction New Delhi, Delhi, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Everstone Capital
& 1 more
-
Employee Count
363
as on Feb 08, 2025
-
Investments & Acquisitions
Blue Medical
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Translumina
Translumina offers a comprehensive portfolio of products and services, including Drug Eluting Stents, Drug Eluting Balloons, PTCA Balloons, and Coronary Balloons.
Devices that release drugs to prevent artery re-narrowing in treatments
Balloons delivering drugs during vascular procedures for better outcomes
Balloons used in angioplasty to open blocked coronary arteries
Specialized balloons for enhancing cardiovascular interventions effectively
Funding Insights of Translumina
Investors in Translumina
Translumina has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Everstone Capital and India SME Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on multiple sectors
|
Locked | Locked | Locked | |
|
Private equity investments in mid-market businesses linked to India and Southeast Asia.
|
Locked | Locked | Locked |
Investor details for Translumina
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Translumina
Translumina has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Blue Medical and Lamed.
Investment portfolio details for Translumina
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Develops stents and catheters
|
Locked | Locked | 1998 | Locked | |
|
Endovascular solutions for thoracic aortic dissections are developed.
|
Locked | Locked | 1989 | Locked |
Complete acquisition details for Translumina
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Translumina
Detailed financials for Translumina
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Translumina Comparisons
Peer comparison for Translumina
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Translumina
Translumina operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as SMT, InspireMD, Vesper Medical, Endospan and Biosensors International, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
SMT is recognized as a developer of cardiovascular medical devices.
|
|
| Locked | Locked | Locked |
Proprietary stent systems with bio-stable mesh are developed and commercialized.
|
|
| Locked | Locked | Locked |
Venous stent system is developed for deep vein disease treatment.
|
|
| Locked | Locked | Locked |
Endovascular stent graft systems for aortic aneurysm repair are developed.
|
|
| Locked | Locked | Locked |
Products for interventional cardiology and critical care procedures
|
|
| Locked | Locked | Locked |
Three-dimensional vascular stents for peripheral vascular disease are developed.
|
Detailed competitors of Translumina
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Translumina
Complete news archive for Translumina
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Translumina
Translumina was founded in 2010 and raised its 1st funding round 9 years after it was founded.
Translumina is headquartered in Hechingen, Germany. It is registered at Hechingen, Baden-wurttemberg, Germany.
Paritosh Arora is the current CEO of Translumina.
As of Feb 08, 2025, the latest employee count at Translumina is 363.
Translumina was founded in 2010 and is based in Hechingen, Germany. Operations focus on the cardiovascular sector, where drug-eluting stents, drug-eluting balloons, coronary balloons, and vascular accessories are produced. Advanced manufacturing facilities are maintained to meet international standards. Innovative technologies for cardiovascular interventions are developed and supplied through these processes.
Translumina offers Drug Eluting Stents, Drug Eluting Balloons, PTCA Balloons, and Coronary Balloons.
Translumina has made 2 acquisitions, including Blue Medical, and Lamed.
Translumina has 2 investors. Key investors include Everstone Capital, and India SME Investments.